197 related articles for article (PubMed ID: 28847765)
21. Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole.
Wingard JR; Merz WG; Rinaldi MG; Johnson TR; Karp JE; Saral R
N Engl J Med; 1991 Oct; 325(18):1274-7. PubMed ID: 1669837
[TBL] [Abstract][Full Text] [Related]
22. Candidaemia in patients with haematological disorders and stem cell transplant.
Al-Anazi K; Al-Jasser A
Libyan J Med; 2006 Nov; 1(2):140-55. PubMed ID: 21526012
[TBL] [Abstract][Full Text] [Related]
23. Fluconazole prophylaxis in preterm infants: a systematic review.
Rios JFDS; Camargos PAM; Corrêa LP; Romanelli RMC
Braz J Infect Dis; 2017; 21(3):333-338. PubMed ID: 28286016
[TBL] [Abstract][Full Text] [Related]
24. Current treatment strategies for disseminated candidiasis.
Spellberg BJ; Filler SG; Edwards JE
Clin Infect Dis; 2006 Jan; 42(2):244-51. PubMed ID: 16355336
[TBL] [Abstract][Full Text] [Related]
25. Épico Project. Development of educational recommendations using the DELPHI technique on invasive candidiasis in non-neutropenic critically ill adult patients.
Zaragoza R; Llinares P; Maseda E; Ferrer R; Rodríguez A;
Rev Iberoam Micol; 2013; 30(3):135-49. PubMed ID: 23727234
[TBL] [Abstract][Full Text] [Related]
26. Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance.
Krcmery V; Barnes AJ
J Hosp Infect; 2002 Apr; 50(4):243-60. PubMed ID: 12014897
[TBL] [Abstract][Full Text] [Related]
27. Fluconazole prophylaxis and Candida fungemia in neutropenic children with malignancies.
Cesaro S; Rossetti F; Perilongo G; Rossi L; Zanesco L
Haematologica; 1993; 78(4):249-51. PubMed ID: 8294059
[TBL] [Abstract][Full Text] [Related]
28. Association of clinical and demographic factors in invasive candidiasis caused by fluconazole-resistant Candida species: a study in 15 hospitals, Medellín, Colombia 2010-2011.
Maldonado NA; Cano LE; De Bedout C; Arbeláez CA; Roncancio G; Tabares AM; Robledo CG; Robledo J;
Diagn Microbiol Infect Dis; 2014 Jun; 79(2):280-6. PubMed ID: 24666706
[TBL] [Abstract][Full Text] [Related]
29. The changing epidemiology of invasive candidiasis: Candida glabrata and Candida krusei as the leading causes of candidemia in hematologic malignancy.
Hachem R; Hanna H; Kontoyiannis D; Jiang Y; Raad I
Cancer; 2008 Jun; 112(11):2493-9. PubMed ID: 18412153
[TBL] [Abstract][Full Text] [Related]
30. Concurrent isolation of Candida krusei and Candida tropicalis from multiple blood cultures in a patient with acute leukemia.
Sandin RL; Meier CS; Crowder ML; Greene JN
Arch Pathol Lab Med; 1993 May; 117(5):521-3. PubMed ID: 8489342
[TBL] [Abstract][Full Text] [Related]
31. Increase in prevalence of nosocomial non-Candida albicans candidaemia and the association of Candida krusei with fluconazole use.
Hope W; Morton A; Eisen DP
J Hosp Infect; 2002 Jan; 50(1):56-65. PubMed ID: 11825053
[TBL] [Abstract][Full Text] [Related]
32. Incidence of candidaemia and relationship with fluconazole use in an intensive care unit.
Bassetti M; Ansaldi F; Nicolini L; Malfatto E; Molinari MP; Mussap M; Rebesco B; Bobbio Pallavicini F; Icardi G; Viscoli C
J Antimicrob Chemother; 2009 Sep; 64(3):625-9. PubMed ID: 19622536
[TBL] [Abstract][Full Text] [Related]
33. Invasive candidiasis during granulocytopenia.
Anaissie E; Pinczowski H
Recent Results Cancer Res; 1993; 132():137-45. PubMed ID: 8265854
[TBL] [Abstract][Full Text] [Related]
34. Candidaemia associated with decreased in vitro fluconazole susceptibility: is Candida speciation predictive of the susceptibility pattern?
Oxman DA; Chow JK; Frendl G; Hadley S; Hershkovitz S; Ireland P; McDermott LA; Tsai K; Marty FM; Kontoyiannis DP; Golan Y
J Antimicrob Chemother; 2010 Jul; 65(7):1460-5. PubMed ID: 20430790
[TBL] [Abstract][Full Text] [Related]
35. Epidemiology of candidemia and antifungal susceptibility in invasive Candida species in the Asia-Pacific region.
Wang H; Xu YC; Hsueh PR
Future Microbiol; 2016 Oct; 11():1461-1477. PubMed ID: 27750452
[TBL] [Abstract][Full Text] [Related]
36. Folliculocentric cutaneous presentation of disseminated Candida krusei infection in a patient with acute myeloid leukemia.
Qi J; Jourabchi N; Balagula Y; Sheu M; Fischer MK
Dermatol Online J; 2015 Nov; 21(11):. PubMed ID: 26632935
[TBL] [Abstract][Full Text] [Related]
37. Candida krusei transmission among hematology patients resolved by adapted antifungal prophylaxis and infection control measures.
Vos MC; Endtz HP; Horst-Kreft D; Doorduijn J; Lugtenburg E; Verbrugh HA; Löwenberg B; de Marie S; van Pelt C; van Belkum A
J Clin Microbiol; 2006 Mar; 44(3):1111-4. PubMed ID: 16517907
[TBL] [Abstract][Full Text] [Related]
38. Epidemiology of invasive candidiasis in a surgical intensive care unit: an observational study.
Aguilar G; Delgado C; Corrales I; Izquierdo A; Gracia E; Moreno T; Romero E; Ferrando C; Carbonell JA; Borrás R; Navarro D; Belda FJ
BMC Res Notes; 2015 Sep; 8():491. PubMed ID: 26415526
[TBL] [Abstract][Full Text] [Related]
39. EPICO PROJECT. Development of educational recommendations using the DELPHI technique on invasive candidiasis in non- neutropenic critically ill adult patients.
Epico Project Group
Rev Esp Quimioter; 2013 Jun; 26(2):131-50. PubMed ID: 23817652
[TBL] [Abstract][Full Text] [Related]
40. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry.
Horn DL; Neofytos D; Anaissie EJ; Fishman JA; Steinbach WJ; Olyaei AJ; Marr KA; Pfaller MA; Chang CH; Webster KM
Clin Infect Dis; 2009 Jun; 48(12):1695-703. PubMed ID: 19441981
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
